FLOT and CROSS chemotherapy regimens alter the frequency of CD27+ and CD69+ T cells in oesophagogastric adenocarcinomas: implications for combination with immunotherapy.
Davern M, Donlon NE, Sheppard AS, Majcher KD, Connell FO, Heeran AB, Grant M, Farrell RA, Hayes C, Bracken-Clarke D, Conroy MJ, Foley E, Toole DO, Bhardwaj A, Ravi N, Reynolds JV, Maher SG, Sullivan JO, Lysaght J.
Davern M, et al.
J Cancer Res Clin Oncol. 2023 Jul;149(7):3753-3774. doi: 10.1007/s00432-022-04283-9. Epub 2022 Aug 20.
J Cancer Res Clin Oncol. 2023.
PMID: 35986757
Free PMC article.